| Hans-Günter Meyer-Thompson | Wechselwirkungen mit Substitutionsmitteln
Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism.
Drug-Drug Interaction Studies of Esmethadone (REL-1017) Involving CYP3A4- and CYP2D6-Mediated Metabolism.
Ferri N, De Martin S, Stuart J, Traversa S, Folli F, Pappagallo M, O'Gorman C, Guidetti C, Mattarei A, Inturrisi CE, Manfredi PL.
Drugs R D. 2023 Nov 27. doi: 10.1007/s40268-023-00450-6. Epub ahead of print. PMID: 38010591.
https://link.springer.com/article/10.1007/s40268-023-00450-6